Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide

EU orphan designation number: EU/3/12/997   
Active ingredient: N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide
Indication: Treatment of schwannoma
Sponsor: Sirius Regulatory Consulting Limited
29 Hambling Meadow, Eddington, Hungerford, Berkshire, RG17 0HJ, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/06/2012 Centralised Orphan - Designation EMA/OD/165/11 (2012)3841 of 06/06/2012